hydrogen carbonate has been researched along with ifosfamide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thigpen, T | 1 |
Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y | 1 |
Palumbo, RC; Robertson, WW; Segal, LS | 1 |
Nissim, I; Weinberg, JM | 1 |
Agaliotis, DP; Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Mattox, T; Perkins, JB; Rosen, RM; Zorsky, PE | 1 |
Bacci, G; Cesari, M; Fasano, MC; Ferrari, S; Lamanna, G; Zolezzi, C | 1 |
Bazari, H; Forman, JP; Humphreys, BD; Magee, CC; Seifter, J; Zandi-Nejad, K | 1 |
Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R | 1 |
1 trial(s) available for hydrogen carbonate and ifosfamide
Article | Year |
---|---|
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Bone Neoplasms; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Kidney Diseases; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prospective Studies | 1999 |
7 other study(ies) available for hydrogen carbonate and ifosfamide
Article | Year |
---|---|
Ifosfamide-induced central nervous system toxicity.
Topics: Bicarbonates; Central Nervous System; Creatinine; Drug Administration Schedule; Humans; Ifosfamide; Serum Albumin | 1991 |
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Ifosfamide; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Sodium; Sodium Bicarbonate | 1990 |
The development of rickets as a complication of chemotherapy for the treatment of Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Calcitriol; Child; Child, Preschool; Fanconi Syndrome; Female; Fractures, Spontaneous; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Radiography; Rickets; Wilms Tumor | 1995 |
Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats.
Topics: Administration, Oral; Animals; Bicarbonates; Blood Urea Nitrogen; Creatinine; Fanconi Syndrome; Glycine; Ifosfamide; Kidney Tubules, Proximal; Male; Maleates; Phosphates; Phospholipids; Rats; Rats, Sprague-Dawley | 1996 |
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Carboplatin; Creatinine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Magnesium; Male; Middle Aged; Neoplasms; Potassium; Retrospective Studies | 1997 |
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Candidiasis; Chlorides; Cytarabine; Etoposide; Fatal Outcome; Fever; Humans; Ifosfamide; Kidney Tubular Necrosis, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Neutropenia; Polycystic Kidney, Autosomal Dominant; Pyrrolidonecarboxylic Acid; Salvage Therapy; Systemic Inflammatory Response Syndrome | 2005 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine | 2013 |